Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imbruvica
Imbruvica
AbbVie Gets FDA Approval for Lymphoma Drug
Yahoo/GuruFocus
Mon, 01/23/17 - 10:24 am
AbbVie
FDA
Imbruvica
marginal zone lymphoma
MZL
3 Biggest Risks for AbbVie in 2017
Motley Fool
Wed, 12/28/16 - 11:03 am
AbbVie
Humira
biosimilars
Imbruvica
Viekira Pak
Elagolix
risankizumab
AbbVie’s Imbruvica Expected to Become a Leading Oncology Drug
Market Realist
Tue, 11/29/16 - 09:46 am
AbbVie
Imbruvica
oncology
CLL
JNJ's Expensive Leukemia Drug Wins British Nod
Investopedia
Sun, 11/27/16 - 03:54 pm
JNJ
UK
Imbruvica
chronic lymphocytic leukemia
CLL
What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J
Fierce Pharma
Thu, 11/17/16 - 10:01 am
Gilead Sciences
Biogen
JNJ
drug launches
AbbVie
Sovaldi
Imbruvica
Tecfidera
3 Things AbbVie's Management Said While Its Stock Got Hammered
Motley Fool
Sat, 10/29/16 - 01:23 pm
AbbVie
earnings
Humira
Imbruvica
Viekira Pak
AbbVie Inc: New Drugs May Overcome Humira Loss
Bidness, ETC
Mon, 08/1/16 - 03:56 pm
AbbVie
Humira
Rova-T
Venclexta
Imbruvica
Viekira Pak
Why AbbVie Continues to Explore Imbruvica for Diffuse Large B-Cell Lymphoma
Market Realist
Wed, 07/6/16 - 09:48 am
AbbVie
Imbruvica
diffuse large B-cell lymphoma
AbbVie Inc Bags Fourth Breakthrough Therapy Status for Imbruvica
Bidness, ETC
Thu, 06/30/16 - 09:35 am
AbbVie
breakthrough therapies
Imbruvica
cGVHD
graft vs host disease
AbbVie Builds Upon Robust Body of IMBRUVICA® (ibrutinib) Data with Phase 3 Longer-Term Studies in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
Yahoo
Mon, 06/6/16 - 11:23 am
AbbVie
Imbruvica
CLL
small lymphocytic lymphoma
ASCO 2016
Updated survival data added to Imbruvica's label
BioPharma Dive
Wed, 05/11/16 - 06:41 pm
Imbruvica
CLL
Janssen
J&J, AbbVie's Imbruvica breaks into larger CLL market with first-line FDA nod
Fierce Pharma
Sat, 03/5/16 - 09:50 am
JNJ
AbbVie
Imbruvica
CLL
FDA
chronic lymphocytic leukemia
Johnson & Johnson’s Imbruvica Sees Increased Sales in 4Q15
Yahoo/Market Realist
Wed, 02/10/16 - 09:33 am
JNJ
Imbruvica
4 Reasons Why Johnson & Johnson Exploded Higher Following Its Q4 Earnings Release
Motley Fool
Thu, 01/28/16 - 09:02 pm
JNJ
earnings
Imbruvica
Invokana
AbbVie Expects Imbruvica Revenues to Reach $5 Billion in 2020
Yahoo/Market Realist
Wed, 01/20/16 - 09:27 pm
AbbVie
Imbruvica
blood cancers
3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next
Motley Fool
Tue, 01/19/16 - 04:24 pm
AbbVie
Humira
Imbruvica
Viekira Pak
AstraZeneca's Acerta deal could put the hurt on AbbVie's Imbruvica
Fierce Pharma Marketing
Tue, 12/22/15 - 10:40 am
AstraZeneca
Acerta
AbbVie
M&A
Imbruvica
Here’s How AbbVie, JNJ May Turn Imbruvica into a $12 Billion Drug
Bidness, ETC
Mon, 12/7/15 - 10:37 am
AbbVie
JNJ
Imbruvica
chronic lymphocytic leukemia
AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
Yahoo
Fri, 11/13/15 - 10:59 am
AbbVie
Imbruvica
bendamustine
rituximab
chronic lymphocytic leukemia
FDA
Execs behind Imbruvica raise $75M for a new cancer project
Fierce Biotech
Wed, 09/30/15 - 10:44 am
Imbruvica
Corbus Pharmaceuticals
cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »